As of Feb 16
| -0.88 / -0.92%|
The 26 analysts offering 12-month price forecasts for Celgene Corp have a median target of 126.50, with a high estimate of 163.00 and a low estimate of 96.00. The median estimate represents a +32.79% increase from the last price of 95.26.
The current consensus among 32 polled investment analysts is to Buy stock in Celgene Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.